高级检索
当前位置: 首页 > 详情页

Updated efficacy and safety of SHR-A1811, an anti-HER2 antibody-drug conjugate, in heavily pretreated advanced solid tumors with HER2-expression or mutations: a global, multicenter, phase 1 study

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Med Oncol, Phase I Clin Trial Ctr, Guangzhou, Peoples R China [2]Zhengzhou Univ, Affiliated Canc Hosp, Henan Breast Canc Ctr, Dept Breast Dis, Zhengzhou, Peoples R China [3]Henan Canc Hosp, Zhengzhou, Peoples R China [4]Tianjin Med Univ Canc Inst & Hosp, Breast Med Oncol, Tianjin, Peoples R China [5]Huazhong Univ Sci & Technol, Dept Breast Surg, Hubei Canc Hosp,Wuhan Clin Res Ctr Breast Canc, Tongji Med Coll,Hubei Prov Clin Res Ctr Breast Can, Wuhan, Peoples R China [6]Nanjing Med Univ, Affiliated Hosp 1, Clin Res, Nanjing, Peoples R China [7]Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Peoples R China [8]Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea [9]Macquarie Univ, Macquarie Med Sch, Sydney, Australia [10]Hunan Canc Hosp, Dept Urinary Surg, Changsha, Peoples R China [11]Seoul Natl Univ, Seoul Natl Univ Bundang Hosp, Coll Med, Hematol & Med Oncol, Seongnam, South Korea [12]Cent South Univ, Xiangya Hosp, Dept Breast Surg, Natl Agency Clin Trial Med, Changsha, Peoples R China [13]Wuhan Univ, Zhongnan Hosp, Radiat & Med Oncol, Wuhan 430071, Peoples R China [14]Alfred Hlth, Med Oncol, Melbourne, Vic, Australia [15]Monash Univ, Cent Clin Sch, Melbourne, Australia [16]Fudan Univ, Shanghai Canc Ctr, Phase 1 Clin Trial Ctr, Shanghai, Peoples R China [17]Montefiore Einstein Ctr Canc Care, Med Oncol, Bronx, NY USA [18]China Med Univ, Shengjing Hosp, Dept Oncol, Shenyang, Peoples R China [19]Fujian Med Univ, Melanoma Urol Soft Tissue Tumor Internal Med, Canc Hosp, Fuzhou, Peoples R China [20]Seoul Natl Univ Hosp, Hematol & Oncol, Seoul 110744, South Korea [21]Chinese Acad Med Sci, Canc Hosp, Gynecol Oncol, Beijing, Peoples R China [22]Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Biliary & Pancreat Surg, Shanghai, Peoples R China [23]PASO Med, Hematol & Oncol, Melbourne, Vic, Australia [24]Mary Crowley Canc Res, Med Oncol, Dallas, TX USA [25]Sichuan Canc Hosp, Dept Breast Surg, Chengdu, Sichuan, Peoples R China [26]Southern Med Univ, Nanfang Hosp, Breast Ctr, Dept Gen Surg, Guangzhou, Peoples R China [27]Hubei Canc Hosp, Hepat Biliary Pancreat Surg, Wuhan, Peoples R China [28]China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Peoples R China [29]Bengbu Med Coll, Affiliated Hosp 1, Surg Oncol, Bengbu, Peoples R China [30]Bengbu Med Coll, Affiliated Hosp 1, Phase 1 Clin Trial Lab, Bengbu, Peoples R China [31]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Breast Surg, Guangzhou 510120, Peoples R China [32]Jiangsu Hengrui Pharmaceut Co Ltd, Oncol Clin Res & Dev, Shanghai, Peoples R China [33]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Breast Tumor Ctr, Guangzhou, Peoples R China
出处:
ISSN:
语种:
WOS:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 2 区 医学
小类 | 2 区 妇产科学 2 区 肿瘤学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 妇产科学 2 区 肿瘤学
JCR分区:
出版当年[2025]版:
最新[2023]版:
Q1 OBSTETRICS & GYNECOLOGY Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2024版]

第一作者:
第一作者机构: [1]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Med Oncol, Phase I Clin Trial Ctr, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:59237 今日访问量:0 总访问量:4856 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号